研究单位：[1]Vice President of Tian Tan Hospital, Director of Neurology Center, Beijing Tiantan Hospital[2]Xuanwu Hospital, Beijing[3]Peking University First Hospital[4]Peking University Third Hospital[5]Tianjin First Central Hospital[6]Tianjin Huanhu Hospital[7]Hebei Medical University Third Hospital[8]The Second Hospital of Hebei Medical University[9]Hebei General Hospital[10]Second Affiliated Hospital, School of Medicine, Zhejiang University[11]First Affiliated Hospital of Wenzhou Medical University[12]Xiangya Hospital of Central South University[13]Guangzhou First People's Hospital
The purpose of the study is to explore safety and efficacy of Salfaprodil administration for patients with acute ischemic stroke within 6 hours of onset.
